GlaxoSmithKline (GSK)

Add to Watchlists
Create an Alert
45.29 +0.11  +0.24% NYSE Jul 29, 12:00 Delayed 2m USD

GlaxoSmithKline Enterprise Value:

134.96B for July 28, 2016
View 4,000+ financial data types
Browse...
View Full Chart

GlaxoSmithKline Enterprise Value Chart

Export Data
Save Image

GlaxoSmithKline Historical Enterprise Value Data

View and export this data going back to 1976. Start your Free Trial
Export Data Date Range:
Data for this Date Range  
July 28, 2016 134.96B
July 27, 2016 134.81B
July 26, 2016 132.47B
July 25, 2016 132.18B
July 22, 2016 131.79B
July 21, 2016 131.11B
July 20, 2016 132.32B
July 19, 2016 131.37B
July 18, 2016 132.64B
July 15, 2016 131.89B
July 14, 2016 131.76B
July 13, 2016 131.47B
July 12, 2016 131.40B
July 11, 2016 130.91B
July 8, 2016 130.57B
July 7, 2016 130.47B
July 6, 2016 131.23B
July 5, 2016 130.86B
July 1, 2016 130.06B
June 30, 2016 130.47B
June 29, 2016 126.74B
June 28, 2016 123.99B
June 27, 2016 121.09B
June 24, 2016 122.69B
June 23, 2016 126.98B
   
June 22, 2016 125.03B
June 21, 2016 124.76B
June 20, 2016 124.37B
June 17, 2016 121.55B
June 16, 2016 122.13B
June 15, 2016 120.84B
June 14, 2016 120.87B
June 13, 2016 122.77B
June 10, 2016 123.01B
June 9, 2016 125.76B
June 8, 2016 126.86B
June 7, 2016 127.32B
June 6, 2016 127.69B
June 3, 2016 127.78B
June 2, 2016 126.62B
June 1, 2016 126.01B
May 31, 2016 126.52B
May 27, 2016 127.44B
May 26, 2016 128.27B
May 25, 2016 128.34B
May 24, 2016 127.35B
May 23, 2016 125.64B
May 20, 2016 125.64B
May 19, 2016 125.18B
May 18, 2016 126.66B

There is no data for the selected date range.

An error occurred. Please try again by refreshing your browser or contact us with details of your problem.

About Enterprise Value

Click "Learn More" below to see how YCharts calculates Enterprise Value.

Enterprise Value (EV) is a valuation metric alternative to traditional market capitalization that reflects the market value of an entire business. Like market cap, EV is a measure of what the market believes a company is worth. Enterprise value captures the cost of an entire business, including debt and equity. It is a sum of claims of all preferred shareholders, debt holders, security holders, common equity holders, and minority shareholders - unlike market cap, which only captures the total value of common equity securities.

EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Learn More

Advertisement

GSK Enterprise Value Benchmarks

Companies
Pfizer 242.63B
AstraZeneca 100.87B
Johnson & Johnson 325.84B

GSK Enterprise Value Range, Past 5 Years

Minimum 112.27B Sep 29 2015
Maximum 160.95B Apr 29 2014
Average 135.59B

GSK Enterprise Value Excel Add-In Codes

  • Metric Code: enterprise_value
  • Latest data point: =YCP("GSK", "enterprise_value")
  • Last 5 data points: =YCS("GSK", "enterprise_value", -4)

To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.

Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.

Advertisement

You've hit the 10 page limit on YCharts.

Experience the power of YCharts.
Start your Free 7-Day Trial.

Start My Free Trial No credit card required.

Already a subscriber? Sign in.

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}
Start your free 7-Day Trial.

{{root.upsell.info.button_text}} No credit card required.

Already a subscriber? Sign in.